Extend PIX301: A phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma

Andreas Engert; Rauol Herbrecht; Armando Santoro; Pier Luigi Zinzani; Igor Gorbatchevsky

Extend PIX301: A phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma

Andreas Engert, Rauol Herbrecht, Armando Santoro, Pier Luigi Zinzani, Igor Gorbatchevsky

Istituto Clinico Humanitas

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	152-154
Number of pages	3
Journal	Clinical Lymphoma and Myeloma
Volume	7
Issue number	2
Publication status	Published - Sep 2006

Keywords

Anthracyclines
Cardiac toxicity
Single-agent therapy

ASJC Scopus subject areas

Cancer Research
Oncology
Hematology

Cite this

Engert, A., Herbrecht, R., Santoro, A., Zinzani, P. L., & Gorbatchevsky, I. (2006). Extend PIX301: A phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma. Clinical Lymphoma and Myeloma, 7(2), 152-154.

Extend PIX301 : A phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma. / Engert, Andreas; Herbrecht, Rauol; Santoro, Armando; Zinzani, Pier Luigi; Gorbatchevsky, Igor.

In: Clinical Lymphoma and Myeloma, Vol. 7, No. 2, 09.2006, p. 152-154.

Research output: Contribution to journal › Article

@article{46036d086ff345778b8a3e0df34c2e23,

title = "Extend PIX301: A phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma",

keywords = "Anthracyclines, Cardiac toxicity, Single-agent therapy",

author = "Andreas Engert and Rauol Herbrecht and Armando Santoro and Zinzani, {Pier Luigi} and Igor Gorbatchevsky",

year = "2006",

month = "9",

language = "English",

volume = "7",

pages = "152--154",

journal = "Clinical Lymphoma and Myeloma",

issn = "1557-9190",

publisher = "Cancer Information Group, LP",

number = "2",

}

TY - JOUR

T1 - Extend PIX301

T2 - A phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma

AU - Engert, Andreas

AU - Herbrecht, Rauol

AU - Santoro, Armando

AU - Zinzani, Pier Luigi

AU - Gorbatchevsky, Igor

PY - 2006/9

Y1 - 2006/9

KW - Anthracyclines

KW - Cardiac toxicity

KW - Single-agent therapy

UR - http://www.scopus.com/inward/record.url?scp=33750147820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750147820&partnerID=8YFLogxK

M3 - Article

C2 - 17026830

AN - SCOPUS:33750147820

VL - 7

SP - 152

EP - 154

JO - Clinical Lymphoma and Myeloma

JF - Clinical Lymphoma and Myeloma

SN - 1557-9190

IS - 2

ER -

Extend PIX301: A phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma

Keywords

ASJC Scopus subject areas

Cite this

Access to Document